Skip to main content
. 2022 Aug 26;70(9):3373–3376. doi: 10.4103/ijo.IJO_256_22

Figure 1.

Figure 1

Mean increase in axial length and refraction of treatment and control group after 24 months of treatment with atropine 0.01% and placebo drug